Dingyuan Luo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dingyuan Luo

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Cancer Biomarkers : Section a of Disease Markers|December 24, 2016

CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinomaDingyuan Luo, Haibo Chen, Penghui Lu, et al.

Oncotarget|May 13, 2017

Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cellsHaibo Chen, Dingyuan Luo, Lin Zhang, et al.

Carcinogenesis|April 18, 2019

Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylationDingyuan Luo, Magdalena Fraga-Lauhirat, Jonathan Millings, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Cancer Biomarkers : Section a of Disease Markers|December 24, 2016

CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinomaDingyuan Luo, Haibo Chen, Penghui Lu, et al.

Oncotarget|May 13, 2017

Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cellsHaibo Chen, Dingyuan Luo, Lin Zhang, et al.

Carcinogenesis|April 18, 2019

Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylationDingyuan Luo, Magdalena Fraga-Lauhirat, Jonathan Millings, et al.

Pageof 3